Literature DB >> 30719684

EBV-Related Hodgkin Lymphoma in an ICF2 Patient: Is EBV Susceptibility a Hallmark of This ICF Subtype?

Francesco Licciardi1, Marlinde van den Boogaard2, Marta Delle Piane3, Pier Angelo Tovo3, Davide Montin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30719684     DOI： 10.1007/s10875-019-00596-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  7 in total

1.  Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.

Authors:  Guillaume Velasco; Giacomo Grillo; Nizar Touleimat; Laure Ferry; Ivana Ivkovic; Florence Ribierre; Jean-François Deleuze; Sophie Chantalat; Capucine Picard; Claire Francastel
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

2.  Hematopoietic Stem Cell Transplantation in a Patient With ICF2 Syndrome Presenting With EBV-Induced Hemophagocytic Lymphohystiocytosis.

Authors:  Esther Harnisch; Emilie P Buddingh; Peter E Thijssen; Alice S Brooks; Gertjan J Driessen; Rogier Kersseboom; Arjan C Lankester
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939

3.  Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey.

Authors:  Delphine Sterlin; Guillaume Velasco; Despina Moshous; Fabien Touzot; Nizar Mahlaoui; Alain Fischer; Felipe Suarez; Claire Francastel; Capucine Picard
Journal:  J Clin Immunol       Date:  2016-02-06       Impact factor: 8.317

4.  Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.

Authors:  M L van den Boogaard; P E Thijssen; C Aytekin; F Licciardi; A A Kıykım; L Spossito; V A S H Dalm; G J Driessen; R Kersseboom; F de Vries; M M van Ostaijen-Ten Dam; A Ikinciogullari; F Dogu; M Oleastro; E Bailardo; L Daxinger; E Nain; S Baris; M J D van Tol; C Weemaes; S M van der Maarel
Journal:  Clin Genet       Date:  2017-03-07       Impact factor: 4.438

5.  Clinical and Immunological Characterization of ICF Syndrome in Japan.

Authors:  Chikako Kamae; Kohsuke Imai; Tamaki Kato; Tsubasa Okano; Kenichi Honma; Noriko Nakagawa; Tzu-Wen Yeh; Emiko Noguchi; Akira Ohara; Tomonari Shigemura; Hiroshi Takahashi; Shunichi Takakura; Masatoshi Hayashi; Aoi Honma; Seiichi Watanabe; Tomoko Shigemori; Osamu Ohara; Hiroyuki Sasaki; Takeo Kubota; Tomohiro Morio; Hirokazu Kanegane; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2018-10-23       Impact factor: 8.317

Review 6.  Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anomalies syndrome. Report of two new patients and review of the literature.

Authors:  P Franceschini; S Martino; M Ciocchini; E Ciuti; M P Vardeu; A Guala; F Signorile; P Camerano; D Franceschini; P A Tovo
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

7.  The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion.

Authors:  Henar Hernando; Claire Shannon-Lowe; Abul B Islam; Fatima Al-Shahrour; Javier Rodríguez-Ubreva; Virginia C Rodríguez-Cortez; Biola M Javierre; Cristina Mangas; Agustín F Fernández; Maribel Parra; Henri-Jacques Delecluse; Manel Esteller; Eduardo López-Granados; Mario F Fraga; Nuria López-Bigas; Esteban Ballestar
Journal:  Genome Biol       Date:  2013-01-15       Impact factor: 13.583
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.